Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort
Objective: To determine if neuropsychiatric and axial motor symptoms at baseline would be predictive of freezing of gait (FoG) at 5-year follow up in participants…Baseline and Longitudinal NSD-ISS Staging of the PPMI Cohort
Objective: To apply biological definition and Neuronal α-Synuclein Disease Integrated Staging System (NSD-ISS) to the PPMI baseline and longitudinal dataset. Background: The NSD-ISS Working Group…Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data
Objective: To evaluate whether clinical and neuroimaging baseline markers predict the onset of significant dysautonomia over five years in individuals with idiopathic, de novo Parkinson's…Research Information Disclosure In The PPMI Study: Development Of A Disclosure Process
Objective: The Parkinson Progression Markers Initiative (PPMI) is a multinational, longitudinal observational study that collects clinical, imaging, biologic, and genetic data from participants with or…Creation and Performance of a Cognitive Summary Score in de novo Parkinson’s Disease: Results from the PPMI Study
Objective: To determine if a cognitive summary score (CSS) is sensitive in detecting early cognitive deficits in de novo Parkinson’s disease (PD). Background: Cognitive impairment…Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis
Objective: To explore piperine as a potential biomarker for Parkinson’s disease (PD) among GBA and LRRK2 mutation carriers and non-carriers. Background: Piperine is a yellow…Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data
Objective: This study evaluates whether clinical, biological, and neuroimaging baseline markers can predict the onset of significant cognitive-based milestones developed in these cohorts over a…Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease
Objective: To investigate whether anxiety, depression, and sleep impairment relate to development of impulse control disorders (ICD) in patients with early-stage Parkinson’s disease (PD). Background:…Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study
Objective: To evaluate the progression of posterior putamen dopaminergic denervation in relation to motor progression in the less affected and more affected side of the…Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update
Objective: To describe the study design and timeline of the first interventional study in Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…
Advanced Search Results
-
Title
--- -
Meeting
2024 International Congress -
Keyword
PPMI